Trial Outcomes & Findings for Marcaine Use in Laparoscopic Gynecological Surgery (NCT NCT01861665)
NCT ID: NCT01861665
Last Updated: 2018-10-12
Results Overview
Pain level on post op day 1 and 2 study hypothesize will be less if Marcaine is administered pre instead of post incision. The pain scale is a numeric pain rating scale from 0-5, with zero being no pain and 5 being the worst pain imaginable, faces depicting no pain to worst pain.
TERMINATED
NA
27 participants
Post surgery day 0, post surgery day 1, post surgery day 2
2018-10-12
Participant Flow
Participant milestones
| Measure |
Medication Pre Incision Left Med Post Incision Right
Subjects acted as their own control with the left side being injected with the medication pre incision and the right side being injected with medication post incision.
|
Medication Pre Incision Right Med Post Incision Left
Subjects acted as their own control with right side being injected with the medication pre incision and left side being injected with the medication post incision.
|
|---|---|---|
|
Overall Study
STARTED
|
10
|
17
|
|
Overall Study
COMPLETED
|
10
|
17
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Medication Pre Incision Left Med Post Incision Right
n=10 Participants
Participants acted as their own control with left side being injected with medication pre incision and right side being injected with medication post incision.
|
Medication Pre Incision Right Med Post Incision Left
n=17 Participants
Participants acted as their own control with right side being injected with medication pre incision and left side being injected with medication post incision.
|
Total
n=27 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
33.6 years
STANDARD_DEVIATION 5.79 • n=10 Participants
|
30.92 years
STANDARD_DEVIATION 3.87 • n=17 Participants
|
32.26 years
STANDARD_DEVIATION 4.83 • n=27 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=10 Participants
|
17 Participants
n=17 Participants
|
27 Participants
n=27 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=10 Participants
|
0 Participants
n=17 Participants
|
0 Participants
n=27 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
United States
|
10 participants
n=10 Participants
|
17 participants
n=17 Participants
|
27 participants
n=27 Participants
|
|
Age, Categorical
<=18 years
|
0 Participants
n=10 Participants
|
0 Participants
n=17 Participants
|
0 Participants
n=27 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
10 Participants
n=10 Participants
|
17 Participants
n=17 Participants
|
27 Participants
n=27 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=10 Participants
|
0 Participants
n=17 Participants
|
0 Participants
n=27 Participants
|
PRIMARY outcome
Timeframe: Post surgery day 0, post surgery day 1, post surgery day 2Pain level on post op day 1 and 2 study hypothesize will be less if Marcaine is administered pre instead of post incision. The pain scale is a numeric pain rating scale from 0-5, with zero being no pain and 5 being the worst pain imaginable, faces depicting no pain to worst pain.
Outcome measures
| Measure |
Marcaine Administered Pre-incision
n=27 Participants
Pre-operative administration, using both the specific drug - Marcaine 0.25%- and total amount - 5cc per incision.
Marcaine- 0.25%: Marcaine 0.25% administered pre-incision.
|
Marcaine Administered Post Incision
n=27 Participants
Post-operative administration, using both the specific drug - Marcaine 0.25%- and total amount - 5cc post incision.
Marcaine- 0.25%: Marcaine 0.25% administered post-incision.
|
|---|---|---|
|
Wong-Baker Faces Pain Rating Scale
Post Op day 0
|
1.675 units on a scale
Standard Deviation 1.39
|
1.6 units on a scale
Standard Deviation 1.42
|
|
Wong-Baker Faces Pain Rating Scale
Post Op day 1
|
2 units on a scale
Standard Deviation 0.97
|
1.85 units on a scale
Standard Deviation 1.45
|
|
Wong-Baker Faces Pain Rating Scale
Post Op day 2
|
1 units on a scale
Standard Deviation 1.6
|
0.75 units on a scale
Standard Deviation 0.65
|
Adverse Events
Marcaine Administered Pre-incision.
Marcaine Administered Post-incision
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Glenn Schattman, Associate Professor
Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine.
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place